In this study of MLL/AF9-AML, we showed that a novel activating mutation of Gnb2 were clearly pathogenic in a mouse leukemia model and that high expression of GNB2 may play a significant role in human MLL-AML. The gene discussed is KMT2A; the disease is leukemia.